Papers: 10.1155/2018/9231835

https://doi.org/10.1155/2018/9231835

Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial

Cited by: 1
Author(s): Mariana Simão Xavier, Anete Trajman, Carolina Arana Stanis Schmaltz, Flávia Marinho Sant’Anna, Ivan Maia, David Jamil Hadad, Pedro Emmanuel Alvarenga Americano do Brasil, Valéria Cavalcanti Rolla
Published: over 7 years ago

Software Mentions 3